title: Successful treatment with bosentan of lower extremity ulcers in a scleroderma patient.
abstract: Digital ulcers are a well-known problem in patients with systemic sclerosis. Lower extremity ulcers are less prevalent but are also a challenging and underestimated complication of the disease causing important pain and morbidity. Bosentan, an oral dual endothelin receptor antagonist, has been shown to be effective in preventing digital ulcers in patients with systemic sclerosis. A few recent observations showed the efficacy of bosentan for accelerating the healing of nondigital ulcers in scleroderma patients. This report deals with a 48-year-old patient with systemic sclerosis who developed painful ulcers on the left ankle and hallux. The ulcers were refractory to a combination of vasodilator therapy with a calcium antagonist and several courses of intravenous prostanoids, low molecular weight heparin, aspirin, simvastatin, and intensive local treatment. Bosentan treatment showed spectacular healing of the ulcers already after 4 months of therapy. This case supports the previous few observations of accelerating wound healing of lower extremity ulcers in systemic sclerosis patients with bosentan treatment.
authors: Department of Dermatology, University Hospital, KU Leuven, Kapucijnenvoer 33, 3000 Leuven, Belgium.
authors: Alix
authors: A
authors: Naert
authors: Petra
authors: P
authors: De Haes
references: Arthritis Rheum. 2004 Dec;50(12):3985-93
references: 15593188
references: Ann Rheum Dis. 2008 Dec;67(12):1784-5
references: 19005155
references: Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii3-7
references: 19487220
references: J Rheumatol. 2008 Sep;35(9):1801-8
references: 18709692
references: Hautarzt. 2007 May;58(5):392-3
references: 17450342
references: Int J Rheumatol. 2010;2010:
references: 20827313
references: Br J Dermatol. 2012 Feb;166(2):417-21
references: 21848685
references: Ann Rheum Dis. 2011 Jan;70(1):32-8
references: 20805294